Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With S… (NCT03280316) | Clinical Trial Compass
UnknownNot Applicable
Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After Surgery
100 participantsStarted 2023-01
Plain-language summary
The investigators' goal is to compare the efficacy of three different management strategies (sacral neuromodulation, botulinum toxin, M receptor antagonist) in treating consistent OAB in patients with SVMs after surgery.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* •Patient diagnosed with spinal vascular diseases including Intradural arteriovenous malformation,Intradural arteriovenous fistula,Dural arteriovenous fistula,Extradural arteriovenous malformation,Paravertebral arteriovenous malformation,Paravertebral arteriovenous fistula,cobbs' syndrome,and other spinal arteriovenous metameric syndromes involve the spinal cord.
* patient not received surgical or interventional treatment before
* patient with normal cardiac, renal and hepatic function
* patient capable of understanding the content of the patient information / Informed Consent Form
* patient willing and able to participate in the registry
* patients have consistent OAB after surgery
Exclusion Criteria:
* •patient received surgical treatment or interventional treatment before
* patient is pregnant
* patient allergic to iodine
* patient unable to complete follow-up
* patient with cerebral lesions
* patient with other spinal lesions
* patient with cardiac, renal or hepatic dysfunction